In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...
In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...
Early vs late onset primary colon adenocarcinoma: Gene expression dependent overall survival in chemotherapy treated TCGA-COAD patients. This is an ASCO Meeting Abstract from the 2026 ASCO ...
To investigate how FOXP3 dE2 affects tumor immune responses, Li and colleagues examined data from patients with triple-negative breast cancer in The Cancer Genome Atlas (TCGA) and analyzed survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results